$1.08
N/A
In chiusura: Nov 18, 4:00 PM EST
$1.13
0.054.63%
Post-mercato: 5:53 PM EST

The average analyst price target for Dogwood Therapeutics is $12, 961.9% above the current price. The one analyst covering it rates it Buy. The latest change came on Sep 30, 2025, when HC Wainwright & Co. raised its price target on Dogwood Therapeutics from $10 to $12 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months